Overview / Abstract: |
Significant developments are currently taking place in the treatment and management paradigm of patients with comorbid conditions associated with gMG creating knowledge gaps for translating these advances into clinical decision-making. This activity will focus on consensus recommendations on how to evaluate and manage comorbid conditions including tolerability of drugs as a therapeutic modality. |
Expiration |
Oct 11, 2022 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
1 |
Accreditation |
ACCME (EXCEL CONTINUING EDUCATION) |
Presenters / Authors / Faculty |
Nicholas J. Silvestri, MD, FAAN |
Activity Specialities / Related Topics |
Immunology / Immunosuppression, Neurology, Ophthalmology / Optometry, Pediatrics |
Sponsors / Supporters / Grant Providers |
AREGENX PHARMACEUTICALS |
Keywords / Search Terms |
EXCEL Continuing Education Generalized myasthenia gravis, myasthenia gravis, neuromuscular disease, neuro-ophthalmology. Free CE CME |